ResMed Inc. vs Energy Select Sector SPDR Fund — how do they compare? ResMed Inc. trades at $230.12 (market cap $31.89B), while Energy Select Sector SPDR Fund trades at $65.13 (market cap $40.84B). The key difference: Energy Select Sector SPDR Fund is the larger of the two by market cap, and ResMed Inc. pays a 1.16% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| RMD | XLE | |
|---|---|---|
Market Cap | $31.89B | $40.84B |
Volume | 618,314 | 50,409,268 |
Sector | Health | — |
52-Week High | $277.88 | $65.93 |
52-Week Low | $182.82 | $42.61 |
Typical Hold Time | 51 Days | 67 Days |
Enterprise Value | $31.24B | — |
Dividend Yield | 1.16% | — |
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $230.05, up 1.8% on the day, with a bullish technical outlook and strong fundamental performance. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS of $2.95 exceeding the $2.89 estimate. Revenue growth is robust, reaching $5.15 billion in 2025, while profitability metrics like a 26.94% net income margin and 24.27% ROE highlight operational efficiency. Recent news includes an upcoming Q1 2027 earnings report and positive analyst commentary on growth prospects driven by demand in sleep therapy.
The investment outlook is positive, supported by earnings momentum, a consensus price target of $242.70, and institutional buying. Key risks include competitive pressures, regulatory investigations, and macroeconomic volatility. The stock offers upside potential but requires monitoring of execution and external challenges.
XLE trades at $65.09, up 2.7% today amid bullish technical signals from moving averages, though oscillators show caution with RSI levels in overbought territory. The energy ETF faces mixed sentiment as oil prices surge above $100 due to Middle East tensions while futures traders bet on a potential 12% sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures affecting energy markets.
Outlook remains volatile with geopolitical risks driving short-term gains but fundamental headwinds from potential oil price corrections. Key risks include oil market volatility and Federal Reserve policy impacts, while technical support at $64-$65 provides near-term stability. Investors should weigh high current energy prices against recessionary pressures that could dampen demand.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →